Information Technology, Improved Access, and Use of Prescription Drugs

dc.contributorAalto-yliopistofi
dc.contributorAalto Universityen
dc.contributor.authorBöckerman, Petri
dc.contributor.authorKortelainen, Mika
dc.contributor.authorLaine, Liisa T.
dc.contributor.authorNurminen, Mikko
dc.contributor.authorSaxell, Tanja
dc.contributor.departmentDepartment of Economicsen
dc.contributor.organizationUniversity of Jyväskylä
dc.contributor.organizationUniversity of Turku
dc.contributor.organizationUniversity of Missouri
dc.contributor.organizationSocial Insurance Institution of Finland
dc.date.accessioned2025-02-24T21:39:48Z
dc.date.available2025-02-24T21:39:48Z
dc.date.issued2025-02
dc.description.abstractWe estimate the effects of health information technology designed to improve access to medication while limiting overuse through easier prescription renewal and improved information provision. We focus on benzodiazepines, a commonly prescribed class of mental health and insomnia medications, which are highly effective but potentially addictive. We study the staggered rollout of a nationwide electronic prescribing system over four years in Finland and use population-wide, individual-level administrative data sets. We find that e-prescribing increases average benzodiazepine use due to increased prescription renewals. The increase is most pronounced for younger patients. E-prescribing can improve the health of elderly patients and may help to balance the access-overuse trade-off. Without additional monitoring for addiction in place, it may, however, also have unintended health consequences for younger patients, who are more likely to develop mental and behavioral health disorders.en
dc.description.versionPeer revieweden
dc.format.mimetypeapplication/pdf
dc.identifier.citationBöckerman, P, Kortelainen, M, Laine, L T, Nurminen, M & Saxell, T 2025, 'Information Technology, Improved Access, and Use of Prescription Drugs', Journal of the European Economic Association, vol. 23, no. 1, pp. 396-430. https://doi.org/10.1093/jeea/jvae034en
dc.identifier.doi10.1093/jeea/jvae034
dc.identifier.issn1542-4766
dc.identifier.issn1542-4774
dc.identifier.otherPURE UUID: c63544db-2a65-45ad-a26d-916a0e753f13
dc.identifier.otherPURE ITEMURL: https://research.aalto.fi/en/publications/c63544db-2a65-45ad-a26d-916a0e753f13
dc.identifier.otherPURE LINK: https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=aalto_pure&SrcAuth=WosAPI&KeyUT=WOS:001283109800001&DestLinkType=FullRecord&DestApp=WOS_CPL
dc.identifier.otherPURE LINK: http://www.scopus.com/inward/record.url?scp=85217675859&partnerID=8YFLogxK
dc.identifier.otherPURE FILEURL: https://research.aalto.fi/files/173420678/BIZ_Information_Technology_Improved_Access_and_Use_of_Prescription_Drugs_jvae034_pdfa2b.pdf
dc.identifier.urihttps://aaltodoc.aalto.fi/handle/123456789/134279
dc.identifier.urnURN:NBN:fi:aalto-202502242549
dc.language.isoenen
dc.publisherOxford University Press
dc.relation.ispartofseriesJournal of the European Economic Associationen
dc.relation.ispartofseriesVolume 23, issue 1, pp. 396-430en
dc.rightsopenAccessen
dc.rightsCC BY
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.titleInformation Technology, Improved Access, and Use of Prescription Drugsen
dc.typeA1 Alkuperäisartikkeli tieteellisessä aikakauslehdessäfi
dc.type.versionpublishedVersion

Files